• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Theravance Inc. (THRX)

    -NasdaqGS
    16.65 Up 0.34(2.08%) 4:00PM EDT
    |After Hours : 16.65 0.00 (0.00%) 4:25PM EDT
    Add to Portfolio
    Prev Close:16.31
    Open:16.29
    Bid:14.00 x 200
    Ask:16.85 x 12500
    1y Target Est:14.20
    Beta:2.78
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:16.14 - 16.69
    52wk Range:10.58 - 31.80
    Volume:475,031
    Avg Vol (3m):791,884
    Market Cap:1.94B
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:1.00 (6.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXUp 2.08%1.94B
    AZNDown 0.59%87.78B
    PFEDown 0.23%211.08B

    Key Statistics

    Forward P/E (1 yr):33.30
    P/S (ttm):116.09
    Ex-Dividend Date:10-Mar-15

    Analysts

    Annual EPS Est (Dec-15) :-0.15
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:3.2
    PEG Ratio (5 yr expected):0.65

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback